Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows Powered by cell-free technology to convert AI-generated candidates into experimental binding data Cambridge, UK and Boston MA, USA: Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its antibody screening service to streamline [...]

Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run SAN FRANCISCO and BOSTON -- Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure any antibody format without code, register proteins of any complexity, and capture metadata at the [...]

Eschborn, Germany – Sino Biological Europe GmbH, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently launched its EliteScience VIP Partnership program, an exclusive premium service tailored to support leading universities, research institutes, biotech companies, and pharmaceutical organizations across Europe. The EliteScience program offers a suite of exclusive benefits with no [...]

UK-based gene therapy CDMO embeds NanoMosaic's Tessie platform across its AAV development and manufacturing services. STEVENAGE, England & WALTHAM, Mass. -- Trisk Bio Ltd, a UK-based AAV contract development and manufacturing organisation (CDMO), and NanoMosaic, Inc., a leader in advanced analytical technologies for cell and gene therapy, today announced a partnership to embed the Tessie [...]

Conference Posters and Presentations at ASGCT Showcase Utility of Countable PCR in Single Molecule Quantification for Cell and Gene Therapy Applications Proof-of-Concept Assay Services Now Available; Count What Counts Grant Program Will Provide Pilot Study to Selected Cell and Gene Therapy Researcher PALO ALTO, Calif. -- Countable Labs, the developer of Countable PCR, the leading [...]

SAN DIEGO -- MileCell Biotechnology ("MileCell") today announced the launch of its newly redesigned website www.milecell-bio.com, delivering an enhanced digital experience for researchers and industry partners worldwide. The company also announced the appointments of Nianwei Lin, PhD, Chief Executive Officer and Wayne Vaz, Chief Commercial Officer. The new website was developed to improve usability, streamline product [...]

CAMBRIDGE, UK – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines. Built [...]

Aptco Group announces the acquisition of BlueScientific, a leading UK-based distributor of advanced scientific instrumentation. The acquisition expands Aptco Group’s footprint across Northern Europe and strengthens application and service capabilities for laboratories and R&D organisations. BlueScientific serves customers across the UK, Ireland, the Netherlands and the Nordics. The company’s deep application expertise complements Aptco Group’s portfolio [...]

Genovis AB and MGI Tech Co., Ltd. today announce a strengthened collaboration to advance RNA sequencing solutions. The companies have expanded their commercial agreement to integrate Genovis’ SEQURNA reagents with MGI Tech’s high-performance sequencing platforms, enabling researchers to benefit from enhanced RNA preservation and improved sequencing performance. The partnership marks an important step for both [...]

TOKYO -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discovery and development. As essential tools for innovative drug R&D, functional cell lines need clear, accessible usage authorization to keep projects [...]